- Home
- UXIN vs CDNA Comparison
UXIN vs CDNA Comparison
Compare UXIN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UXIN
- CDNA
- Stock Information
- Founded
- UXIN 2011
- CDNA 1998
- Country
- UXIN China
- CDNA United States
- Employees
- UXIN N/A
- CDNA N/A
- Industry
- UXIN Business Services
- CDNA Medical Specialities
- Sector
- UXIN Consumer Discretionary
- CDNA Health Care
- Exchange
- UXIN Nasdaq
- CDNA Nasdaq
- Market Cap
- UXIN 721.6M
- CDNA 712.2M
- IPO Year
- UXIN 2018
- CDNA 2014
- Fundamental
- Price
- UXIN $3.33
- CDNA $14.02
- Analyst Decision
- UXIN
- CDNA Buy
- Analyst Count
- UXIN 0
- CDNA 8
- Target Price
- UXIN N/A
- CDNA $26.86
- AVG Volume (30 Days)
- UXIN 236.5K
- CDNA 1.4M
- Earning Date
- UXIN 09-23-2025
- CDNA 11-03-2025
- Dividend Yield
- UXIN N/A
- CDNA N/A
- EPS Growth
- UXIN N/A
- CDNA N/A
- EPS
- UXIN 0.94
- CDNA 1.00
- Revenue
- UXIN $300,239,165.00
- CDNA $340,826,000.00
- Revenue This Year
- UXIN N/A
- CDNA $13.02
- Revenue Next Year
- UXIN N/A
- CDNA $12.85
- P/E Ratio
- UXIN $3.73
- CDNA $13.99
- Revenue Growth
- UXIN 58.48
- CDNA 14.72
- 52 Week Low
- UXIN $1.46
- CDNA $10.96
- 52 Week High
- UXIN $7.84
- CDNA $32.97
- Technical
- Relative Strength Index (RSI)
- UXIN 42.65
- CDNA 56.93
- Support Level
- UXIN $3.21
- CDNA $13.23
- Resistance Level
- UXIN $3.64
- CDNA $13.80
- Average True Range (ATR)
- UXIN 0.32
- CDNA 0.69
- MACD
- UXIN -0.00
- CDNA 0.17
- Stochastic Oscillator
- UXIN 14.60
- CDNA 90.16
About UXIN Uxin Limited ADS
Uxin Ltd is an investment holding company. Along with its subsidiaries, the firm operates used car e-commerce platforms through its mobile applications and websites. It facilitates used car transaction services and financing solutions offered by third-party financing partners to buyers for their used car purchases. The company generates revenue through sales of the commission of salvage car sales, and interest income from the financial lease. The Group generates its revenues in China, and assets of the company are also located in China Area.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.